Paysign publishes transcript of Q2 2026 earnings call

PUBT · 1d ago
Paysign publishes transcript of Q2 2026 earnings call
  • Paysign held its Q2 2026 earnings call with CEO Mark Newcomer, CFO Jeff Baker, President of Patient Affordability Matt Turner, Chief Payments Officer Matt Lanford.
  • Revenue rose 48.1% to USD 28.3 million; net income reached USD 6.8 million, gross margin expanded 170 bps to 63.3%.
  • Patient affordability revenue climbed 88.9% to USD 14.6 million; claims increased about 54%; active programs rose to 148 from 97.
  • Plasma revenue increased 21.4% to USD 13 million; monthly revenue per center rose to USD 7,699; center count ended at 561.
  • Raised 2026 outlook to revenue of USD 114-117 million; adjusted EBITDA of USD 35-38 million; expects 165-170 active programs by Q3 end.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Paysign Inc. published the original content used to generate this news brief on August 07, 2026, and is solely responsible for the information contained therein.